323 related articles for article (PubMed ID: 19686384)
1. Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology.
Danzer KM; Krebs SK; Wolff M; Birk G; Hengerer B
J Neurochem; 2009 Oct; 111(1):192-203. PubMed ID: 19686384
[TBL] [Abstract][Full Text] [Related]
2. Different species of alpha-synuclein oligomers induce calcium influx and seeding.
Danzer KM; Haasen D; Karow AR; Moussaud S; Habeck M; Giese A; Kretzschmar H; Hengerer B; Kostka M
J Neurosci; 2007 Aug; 27(34):9220-32. PubMed ID: 17715357
[TBL] [Abstract][Full Text] [Related]
3. Selective loss of dopaminergic neurons and formation of Lewy body-like aggregations in alpha-synuclein transgenic fly neuronal cultures.
Park SS; Lee D
Eur J Neurosci; 2006 Jun; 23(11):2908-14. PubMed ID: 16819979
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease.
Angot E; Brundin P
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S143-7. PubMed ID: 20082977
[TBL] [Abstract][Full Text] [Related]
5. Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
Hansen C; Li JY
Trends Mol Med; 2012 May; 18(5):248-55. PubMed ID: 22503115
[TBL] [Abstract][Full Text] [Related]
6. Distinct higher-order α-synuclein oligomers induce intracellular aggregation.
Illes-Toth E; Ramos MR; Cappai R; Dalton C; Smith DP
Biochem J; 2015 Jun; 468(3):485-93. PubMed ID: 25851527
[TBL] [Abstract][Full Text] [Related]
7. Extracellular α-synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane.
Pacheco CR; Morales CN; Ramírez AE; Muñoz FJ; Gallegos SS; Caviedes PA; Aguayo LG; Opazo CM
J Neurochem; 2015 Mar; 132(6):731-41. PubMed ID: 25669123
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of overexpression of wild-type and mutant human alpha-synuclein on MPP+-induced neurotoxicity in PC12 cells.
Qian JJ; Cheng YB; Yang YP; Mao CJ; Qin ZH; Li K; Liu CF
Neurosci Lett; 2008 Apr; 435(2):142-6. PubMed ID: 18342443
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology.
Gerard M; Deleersnijder A; Daniëls V; Schreurs S; Munck S; Reumers V; Pottel H; Engelborghs Y; Van den Haute C; Taymans JM; Debyser Z; Baekelandt V
J Neurosci; 2010 Feb; 30(7):2454-63. PubMed ID: 20164329
[TBL] [Abstract][Full Text] [Related]
10. Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.
Pham CL; Leong SL; Ali FE; Kenche VB; Hill AF; Gras SL; Barnham KJ; Cappai R
J Mol Biol; 2009 Apr; 387(3):771-85. PubMed ID: 19361420
[TBL] [Abstract][Full Text] [Related]
11. Sensitive fluorescence polarization technique for rapid screening of alpha-synuclein oligomerization/fibrillization inhibitors.
Luk KC; Hyde EG; Trojanowski JQ; Lee VM
Biochemistry; 2007 Nov; 46(44):12522-9. PubMed ID: 17927212
[TBL] [Abstract][Full Text] [Related]
12. Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods.
Tarutani A; Arai T; Murayama S; Hisanaga SI; Hasegawa M
Acta Neuropathol Commun; 2018 Apr; 6(1):29. PubMed ID: 29669601
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of alpha-synuclein fibrillization by dopamine analogs via reaction with the amino groups of alpha-synuclein. Implication for dopaminergic neurodegeneration.
Li HT; Lin DH; Luo XY; Zhang F; Ji LN; Du HN; Song GQ; Hu J; Zhou JW; Hu HY
FEBS J; 2005 Jul; 272(14):3661-72. PubMed ID: 16008565
[TBL] [Abstract][Full Text] [Related]
14. [Effect of repeated acute hypoxic treatment on the expression of alpha-synuclein in the mouse brain cortex].
Yu S; Liu XM; Li YH; Lu GW; Chen B
Sheng Li Xue Bao; 2004 Apr; 56(2):263-8. PubMed ID: 15127141
[TBL] [Abstract][Full Text] [Related]
15. Modulation of human α-synuclein aggregation by a combined effect of calcium and dopamine.
Jain MK; Bhat R
Neurobiol Dis; 2014 Mar; 63():115-28. PubMed ID: 24269918
[TBL] [Abstract][Full Text] [Related]
16. Cleavage of normal and pathological forms of alpha-synuclein by neurosin in vitro.
Kasai T; Tokuda T; Yamaguchi N; Watanabe Y; Kametani F; Nakagawa M; Mizuno T
Neurosci Lett; 2008 May; 436(1):52-6. PubMed ID: 18358605
[TBL] [Abstract][Full Text] [Related]
17. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
Leong SL; Pham CL; Galatis D; Fodero-Tavoletti MT; Perez K; Hill AF; Masters CL; Ali FE; Barnham KJ; Cappai R
Free Radic Biol Med; 2009 May; 46(10):1328-37. PubMed ID: 19248830
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein transfers from neurons to oligodendrocytes.
Reyes JF; Rey NL; Bousset L; Melki R; Brundin P; Angot E
Glia; 2014 Mar; 62(3):387-98. PubMed ID: 24382629
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal effects of alpha-synuclein overexpression and proteasome inhibition in neuronal cells and tissue.
Dyllick-Brenzinger M; D'Souza CA; Dahlmann B; Kloetzel PM; Tandon A
Neurotox Res; 2010 Apr; 17(3):215-27. PubMed ID: 19653055
[TBL] [Abstract][Full Text] [Related]
20. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein.
Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B
Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]